Novarad Corporation

For more than three decades, Novarad has provided cutting-edge imaging solutions tailored to the needs of hospitals and healthcare providers worldwide. Specializing in radiology, cardiology, mammography, and orthopedics, Novarad has consistently elevated standards of care. 

In 2018, Novarad embarked on a new frontier, leveraging their expertise in medical imaging to emerge as a leader in surgical guidance. This endeavor culminated in the groundbreaking development of VisAR—an Augmented Reality Surgical Navigation System. In May of 2022, VisAR achieved a monumental milestone with the receipt of FDA clearance for intraoperative use. 

VisAR revolutionizes surgical practice by seamlessly translating patient imaging data into a three-dimensional holographic representation. This dynamic visualization, meticulously superimposed over the patient's anatomy, empowers surgeons with unparalleled precision and accuracy, reaching submillimeter levels. Notably, VisAR boasts the most compact operational footprint of any system currently available on the market.